In colorectal cancer (CRC) patient-derived samples, FTO is found at low expression levels, whereas PCIF1 exhibits high expression levels (Relier et al., 2021; Wang et al., 2023a). This evidence concerns the gene PCIF1 and colorectal carcinoma.